Abstract
Together with serum ferritin, erythrocyte ferritincan be a valuable diagnostic tool for evaluating the degree of impaired iron metabolism in different diseases. We collected peripheral blood samples from 64 subjects (22 healthy volunteers, 20 patients with hereditary hemochromatosis, and 22 patients on regular hemodialysis with secondary anemia) to evaluate whether an immunoenzymatic method generally used for serum ferritin can also be used to determine erythrocyte ferritin levels under various conditions of body iron status. Serum and erythrocyte ferritin levels were assayed in parallel using a microparticle enzyme immunoassay (MEIA) IMx-Ferritin kit and an IMx analyzer. The inter-assay imprecision of the serum and erythrocyte ferritin assays was 4.9% and 5.05%, the intra-assay imprecision was 2.2% and 2.3%, and the mean recovery was 102% (range 96–105%) and 101% (range 99–105%), respectively. Both serum and erythrocyte ferritin assays showed a detection limit of 1μg/L and good linearity (R 2=0.99) in the intervals 13.9–443 and 3.9–135.6μg/L, respectively. Our findings demonstrate that the IMx-Ferritin assay currently used to measure serum ferritin levels can also be adopted to measure erythrocyte ferritin insofar as it clearly discriminates high and low erythrocyte ferritin levels in cases of both iron overload and deficiency.
References
1 Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996; 1275: 161–203. 10.1016/0005-2728(96)00022-9Search in Google Scholar
2 Arosio P, Adelman TG, Drysdale JW. On ferritin heterogeneity – further evidence for heteropolymers. J Biol Chem 1978; 253: 4451–8. 10.1016/S0021-9258(17)34741-5Search in Google Scholar
3 Walters GO, Miller FM, Worwood M. Serum ferritin concentration and iron stores in normal subjects. J Clin Pathol 1973; 26: 770–2. 10.1136/jcp.26.10.770Search in Google Scholar
4 Brown RD, Benfatto J, Gibson J, Kronenberg H. Red cell ferritin and iron stores in patients with chronic disease. Eur J Haematol 1988; 40: 136–41. 10.1111/j.1600-0609.1988.tb00810.xSearch in Google Scholar
5 Cazzola M, Dezza L, Bergamaschi G, Barosi G, Bellotti V, Caldera D, et al. Biological and clinical significance of red cell ferritin. Blood 1983; 62: 1078–87. 10.1182/blood.V62.5.1078.1078Search in Google Scholar
6 Cazzola M, Arosio P, Barosi G, Bergamaschi G, Dezza L, Ascari E. Ferritin in the red cells of normal subjects and patients with iron deficiency and iron overload. Br J Haematol 1983; 53: 659–65. 10.1111/j.1365-2141.1983.tb07317.xSearch in Google Scholar
7 Cazzola M, Ascari E. Red cell ferritin as a diagnostic tool. Br J Haematol 1986; 62: 209–13. 10.1111/j.1365-2141.1986.tb02923.xSearch in Google Scholar
8 Brunati C, Piperno A, Guastoni C, Perrino ML, Civati G, Teatini U, et al. Erythrocyte ferritin in patients on chronic hemodialysis treatment. Nephron 1990; 54: 219–23. 10.1159/000185858Search in Google Scholar
9 Christopoulou V, Varsou A, Travlou A, Drivas G. Erythrocyte ferritin in patients with chronic renal failure and heterozygous beta-thalassemia. Nephron 2002; 91: 463–7. 10.1159/000064288Search in Google Scholar
10 Van der Weyden MB, Fong H, Hallman L, Breidahl MJ. A rapid and simple assay for human erythrocyte ferritin. Clin Chim Acta 1983; 127: 397–40. 10.1016/0009-8981(83)90167-5Search in Google Scholar
11 Bamonti-Catena F, Porcella A, Pomati M, Franzini C, Rosina M, Cavalca V, et al. Whole blood folate concentrations: comparison between Stratus Folate (DADE) and radioassay (DPC) methods. Eur J Clin Chem Clin Biochem 1997; 35: 781–5. Search in Google Scholar
12 Pietrangelo A. Hereditary hemochromatosis. A new look at an old disease. N Engl J Med 2004; 350: 2383–97. 10.1056/NEJMra031573Search in Google Scholar
13 Gordeuk VR, Bacon BR, Brittenham GM. Iron overload: causes and consequences. Annu Rev Nutr 1987; 7: 458–508. 10.1146/annurev.nu.07.070187.002413Search in Google Scholar
14 Pietrangelo A. Iron-induced oxidant stress in alcoholic liver fibrogenesis. Alcohol 2003; 30: 121–9. 10.1016/S0741-8329(03)00126-5Search in Google Scholar
15 Drueke T, Witko-Sarsat V, Massy Z, Descamps-Latscha B, Guerin AP, Marchais SJ, et al. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 2002; 106: 2212–7. 10.1161/01.CIR.0000035250.66458.67Search in Google Scholar
16 Winearls CG, Oliver DO, Pippard MJ, Reid C, Downing MR, Cotes PM. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 1986; 2: 1175–8. 10.1016/S0140-6736(86)92192-6Search in Google Scholar
17 Anastassiades EG, Howarth D, Howarth J, Shanks D, Waters HM, Hyde K, et al. Monitoring of iron requirements in renal patients on EPO. Nephrol Dial Transplant 1993; 8: 846–53. Search in Google Scholar
© by Walter de Gruyter Berlin New York